Bud Genius Receives Funding Commitment from Angel
Post# of 5949
Posted On: 08/21/2014 3:15:08 PM
Bud Genius Receives Funding Commitment from Angel Investor
Funding to establish Bud Genius’ (OTC:RIGH) new subsidiary, called Genius Biotech Corporation, was received last week, and an angel investment group has committed to putting in initial capital for the new project, which will more than double the scope of the company's business.
Regarding the group of angel investors who have committed to putting in capital, Stanz said, “We think it was a great deal for the investors who put money into the project, and also will be a great deal for us. They were very demanding about wanting full reporting, audits, and internal financial controls. All of our shareholders will benefit from this."
The funding commitment will pay for certain company expenses to be announced after paperwork has been signed.
About Bud Genius
An early leader in an industry that many are speculating will grow, Bud Genius is one of the first established analytical cannabis laboratories in the United States. Bud Genius was launched to bring vendors together with doctors, patients, and dispensaries that require certified products held to demanding standards. Bud Genius has a vision to expand across the US and abroad serving as the beacon of quality for medical cannabis and adult-use marijuana through the formation of regional laboratories. Certification, data collection, and online reports are the measure by which the company gains.
For more information please visit:
http://www.BudGenius.com
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Bud Genius
Angel Stanz, Chief Executive Officer
855-723-32837
PR@BudGenius.com
Funding to establish Bud Genius’ (OTC:RIGH) new subsidiary, called Genius Biotech Corporation, was received last week, and an angel investment group has committed to putting in initial capital for the new project, which will more than double the scope of the company's business.
Regarding the group of angel investors who have committed to putting in capital, Stanz said, “We think it was a great deal for the investors who put money into the project, and also will be a great deal for us. They were very demanding about wanting full reporting, audits, and internal financial controls. All of our shareholders will benefit from this."
The funding commitment will pay for certain company expenses to be announced after paperwork has been signed.
About Bud Genius
An early leader in an industry that many are speculating will grow, Bud Genius is one of the first established analytical cannabis laboratories in the United States. Bud Genius was launched to bring vendors together with doctors, patients, and dispensaries that require certified products held to demanding standards. Bud Genius has a vision to expand across the US and abroad serving as the beacon of quality for medical cannabis and adult-use marijuana through the formation of regional laboratories. Certification, data collection, and online reports are the measure by which the company gains.
For more information please visit:
http://www.BudGenius.com
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Bud Genius
Angel Stanz, Chief Executive Officer
855-723-32837
PR@BudGenius.com
(0)
(0)